“Not only does it enable standardization, but it is practically also a cleanroom in itself.”
www.miltenyibiotec.com/lp/10-...
Over the past ten years, our customers have experienced the transformative advantages of the CliniMACS Prodigy in manufacturing a wide range of cell products. Explore their insights into the platform!
In 2013, we launched the CliniMACS Prodigy, ready to revolutionize cell and gene therapy manufacturing. Since then, this platform has become a cornerstone in both clinical and industrial settings. It has undergone numerous upgrades and now offers many automated applications, customized services, and modules for integrated electroporation, formulation, and filling.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.